Functional Roles of Thrombopoietin-c-mpl System in Essential Thrombocythemia

References

• Wehmeier A., Scharf R.E., Fricke S., Schneider W. Bleeding and thrombosis in chronic myeloproliferative didorders: Relations of platelet disorders to clinical aspects of the disease. Haemostasis 1989; 19: 251–259
   PubMedGoogle Scholar
• Schafer AL. Bleeding and thrombosis in the myelo-proliferative disorders. Blood 1984; 64: 1–12
   PubMed Web of Science ®Google Scholar
• Fenaux P., Simon M., Caulier M.T., Lai J.L., Goudemand J., Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990; 66: 549–556
   PubMed Web of Science ®Google Scholar
• Chistolini A., Mazzucconi M.G., Ferrari A., La Verde G., Ferrzza G., Gragoni F., Vitale F., Arcieri R., Mandelli F. Essential thrombocythemia: A retrospective study on the clinical course of 100 patients. Haematologica 1990; 75: 537–540
   PubMed Web of Science ®Google Scholar
• Fialkow P.J., Faguet G.B., Jacobson R.J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• El-Kasser N., Hetet G., Briere J., Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets. Blood 1997; 89: 123–134
   Web of Science ®Google Scholar
• Mazur E.M., Cohen J.L., Bogart L. Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia. Blood 1988; 71: 1544–1550
   PubMed Web of Science ®Google Scholar
• Zauli G., Catani L., Gugliotta L., Gaggioli L., Vitale L., Mattioli M., Aglietta M., Bagnara G.P. Essential thrombocythemia: impaired regulation of megakaryocyte progenitors. Int J Cell Cloning 1991; 9: 43–56
   PubMedGoogle Scholar
• Battegay E.J., Thomssen C., Nissen C., Gudat F., Speck B. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol 1989; 42: 321–326
   PubMed Web of Science ®Google Scholar
• Grossi A., Vannucchi A.M., Rafanelli D., Vannucchi L., Ferrini P.R. Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases. Am J Hematol 1987; 25: 371–376
   PubMed Web of Science ®Google Scholar
• Komatsu N., Suda T., Sakata Y., Eguchi M., Kaji K., Saito M., Miura Y. Megakaryocytopoiesis in vitro of patients with thrombocythemia: effect of plasma and serum on megakaryocytic colony formation. Br J Hamatol 1986; 64: 241–252
   PubMed Web of Science ®Google Scholar
• Han Z.C., Briere J., Abgrall J.F., Sensebe L., Parent D., Guern G. Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system. Exp Hamatol 1987; 17: 46–52
   Web of Science ®Google Scholar
• Hehlmann R., John M., Baumann B., Kopcke W. Essential thrombocythemia. Cancer 1988; 61: 2487–2496
   PubMed Web of Science ®Google Scholar
• Bellucci S., Janvier M., Tobelem G., Flandrin G., Charpak Y., Berger R., Boiron M. Essential thrombocythemias. Cancer 1986; 58: 2440–2447
   PubMed Web of Science ®Google Scholar
• Cortellazzo S., Barbui T., Bassan R., Dini E. Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Thromb Haemost 1980; 43: 127–130
   PubMed Web of Science ®Google Scholar
• Preston F.E., Mwth J.F., Stewart R.W., Davies-Jones G.A.B. Thrombocytosis, circulating platelets aggregates and neurological dysfunction. Br Med J 1979; 2: 1561–1563
   PubMed Web of Science ®Google Scholar
• Bazzan M., Tamponi G., Schinco P., Marranca D., Pileri A., Bertello F., Pennone M., Bassignana A., Casaccia M. Platelet behavior in essential thrombocythemia: A study of 31 cases. Eur J Haematol 1989; 43: 350–351
   PubMed Web of Science ®Google Scholar
• Wehmeier A., Fricke S., Scharf R.E., Schneider W. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders. Eur J Haematol 1990; 45: 191–197
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419–431
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lok S., Holly R.D., Broudy V.C., Lin N., Bailey M.C., Forstrom J.W., Buddle M.M., Oort P.J., Hagen F.S., Roth G.J., Papayannopoulou T., Foster D.C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• Farese A.M., Hunt P., Boone T., MacVittie T.J. Recombinant human megakaryocyte growth and development factor stimulates thrombopoiesis in normal nonhuman primates. Blood 1995; 85: 54–59
   Google Scholar
• Zeigler F.C., Sauvage F., Widmer H.R., Keller G.A., Donahue C., Schreiber R.D., Malloy B., Hass P., Eaton D., Matthws W. In vitro megakaryopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045–4052
   PubMed Web of Science ®Google Scholar
• Gurney A.L., Carver-Moore K., Sauvage F.J., Moore M.W. Thrombocytopenia in c-mpl-deficient mice. Science 1994; 265: 1445–1447
   PubMed Web of Science ®Google Scholar
• Alexander W.S., Robert A.W., Nicola N.A., Li R., Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages abd defective megakaryocyto-poiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996; 87: 2162–2170
   PubMed Web of Science ®Google Scholar
• de Sauvage F.J., Carver-Moor K., Luoh S.M., Ryan A., Dowd M., Eaton D.L., Moore M.W. Physiological regulation of early and late stages of megakaryopoiesis by thrombopoietin. J Exp Med 1996; 183: 651–656
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Oda A., Drucker B.J., Kato T., Miyazaki H., Handa M., Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and She in human blood platelets. Blood 1995; 86: 23–27
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Oda A., Druker B.J., Miyazaki H., Handa M., Ohashi H., Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of STAT3 and STAT5 in human blood platelets. Blood 1996; 87: 439–446
   PubMed Web of Science ®Google Scholar
• Ezumi Y., Takayama H., Okuma M. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, Jak2, and STAT3, and enhances agonist-induced aggregation in platelets in vitro. FEBS Letters 1995; 374: 48–52
   PubMed Web of Science ®Google Scholar
• Kojima H., Hamazaki Y., Nagata Y., Todokoro K., Nagasawa T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 1995; 74: 1541–1545
   PubMed Web of Science ®Google Scholar
• Chen J., Herceg-Harjacek, Groopman J.E., Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand thrombopoietin. Blood 1995; 86: 4054–4062
   PubMed Web of Science ®Google Scholar
• Kuter D.J., Rosenverg R.D. Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood 1994; 84: 1464–1472
   PubMed Web of Science ®Google Scholar
• Stoffel R., Wiestner A., Skoda R.C. Thrombopoietin in the thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567–573
   PubMed Web of Science ®Google Scholar
• Fielder P.J., Gurney A.L., Stefanich E., Marian M., Moore M.W., Carver-Moore K., de Sauvage F.J. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996; 87: 2154–2161
   PubMed Web of Science ®Google Scholar
• Fielder P.J., Hass P., Nagel M., Stefanich E., Widmer R., Bennett G.L., Keller G.-A., de Sauvage F.J., Eaton D. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997; 89: 2782–2788
   PubMed Web of Science ®Google Scholar
• Stefanich E., Senn T., Widmer R., Frantino C., Keller G.-A., Fielder P. J. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood 1997; 89: 4063–4070
   PubMed Web of Science ®Google Scholar
• Horikawa Y., Matsumura I., Hashimoto K., Shiraga M., Kosugi S., Tadokoro S., Kato T., Miyazaki H., Tomiyama Y., Kurata Y., Matsuzawa Y., Kanakura Y. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 1997; 90: 4031–4038
   PubMed Web of Science ®Google Scholar
• Kosugi S., Kurata Y., Tomiyama Y., Tahara T., Kato T., Tadokoro S., Shiraga M., Honda S., Kanakura Y., Matsuzawa Y. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Brit J Haematol 1996; 93: 704–706
   PubMed Web of Science ®Google Scholar
• Ichikawa N., Ishida F., Shimodaira S., Tahara T., Kato T., Kitano K. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Thromb Haemost 1996; 76: 156–160
   PubMed Web of Science ®Google Scholar
• Tahara T., Usuki K., Sato H., Ohashi H., Morita H., Tsumura H., Matsumoto A., Miyazaki H., Urabe A., Kato T. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haematopoietic disorders. Brit J Haematol 1996; 93: 783–788
   PubMed Web of Science ®Google Scholar
• Emmons R.V.B., Reid D.M., Cohen R.L., Meng G., Young G.M., Dunber C.E., Shulman N.R. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068–4071
   PubMed Web of Science ®Google Scholar
• Cerutti A., Custodi P., Duranti M., Noris P., Balduini C. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Brit J Haematol 1997; 99: 281–284
   PubMed Web of Science ®Google Scholar
• Moliterno A.R., Hankins D., Spivak J.L. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New Eng J Med 1998; 338: 572–580
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Kato T., Ikeda H., Ishikawa J., Horikawa Y., Hashimoto K., Moriyama Y., Tsujimura T., Nishiura T., Miyazaki H., Matsuzawa Y. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703–708
   PubMed Web of Science ®Google Scholar
• Vigon I., Mornon J.P., Cocault L., Mitjavila M.T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of MPL, the human homolog of v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992; 89: 5640–5644
   PubMed Web of Science ®Google Scholar
• Deveaux S., Filipe A., Lemarchandel V., Ghysdael J., Romeo P.-H., Mignotte V. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 1996; 87: 4678–4685
   PubMed Web of Science ®Google Scholar
• Lemarchandel V., Ghysdael J., Mignotte V., Rahuel C., Romeo P.-H. GATA and Ets cis-acting sequences mediate megakaryocyte specific expression. Mol Cell Biol 1993; 13: 668–676
   PubMed Web of Science ®Google Scholar
• Kaywin P., McDonough M., Insel P., Shattil S.J. Platelet function in essential thrombocythemia: Decreased epinephrine responsiveness associated with a deficiency of platelet α-adrenergic receptors. New Eng J Med 1978; 299: 505–509
   PubMed Web of Science ®Google Scholar
• Schafer A.I. Defiencies of platelet lipoxygenase activity in myeloproliferative disorders. New Eng J Med 1982; 306: 381–386
   PubMed Web of Science ®Google Scholar
• Cooper B., Schafer A.I., Puchalsky D., Handin R.I. Platelet resistance to prostagrandin D2 in patients with myeloproliferative disorders. Blood 1978; 52: 618–626
   PubMed Web of Science ®Google Scholar
• Moore A., Nachman R.L. Platelet Fc receptor: Increased expression in myeloproliferative disease. J Clin Invest 1981; 67: 1064–1071
   PubMed Web of Science ®Google Scholar
• Lowenberg B., Touw P. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281–292
   PubMed Web of Science ®Google Scholar
• Furitsu T., Tsujimura T., Tono T., Ikeda H., Kitayama H., Koshimizu U., Sugahara H., Butterfield J.H., Ashman L.K., Kanayama Y., Matsuzawa Y., Kitamura Y., Kanakura Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736–1744
   PubMed Web of Science ®Google Scholar
• Li Y, Hetet G., Kiladjian J.-J., Gardin C., Grandchamp B., Briere J. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Brit J Haematol 1996; 92: 60–66
   PubMed Web of Science ®Google Scholar
• Kiladjian J.J., Elkasser N., Hetet G., Briere J., Grandchamp B., Gardin C. Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia 1997; 11: 1821–1826
   PubMed Web of Science ®Google Scholar
• Williams E.C., Shahidi N.T. Benign familial thrombocytosis. Am J Hematol 1991; 37: 124–125
   PubMed Web of Science ®Google Scholar
• Schlemper R.J., van der Maas A.P.C., Eikenboom J.C.J. Familial essential thrombocythemia: clinical characteristics of 11 cases in one family. Ann Hematol 1994; 68: 153–158
   PubMed Web of Science ®Google Scholar
• Wiestner A., Schlemper R.J., van der Maas A.P.C., Skoda R.C. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nature Genetics 1998; 18: 49–52
   PubMed Web of Science ®Google Scholar